HYTANBIO CDMO / Cosmetic Microneedle DevelopmentR&D → PILOT → TRANSFER → SCALE
HYTANBIO / CDMO KNOWLEDGE SYSTEM

About HYTANBIO Microneedle CDMO

An integrated cosmetic microneedle development platform linking scientific review, pilot transfer and commercial manufacturing.

Integrated development and manufacturing

Founded in 2026 in Hong Kong for global overseas business, Hytanbio Tech works with an in-house commercial manufacturing base established in 2014 in Shaoxing, Mainland China. Our public program focuses on cosmetic-grade peptide materials and innovative cosmetic delivery systems.

HYTANBIO cosmetic microneedle development work

From scientific question to controlled process

Our team connects formula feasibility, prototype planning, specification alignment, pilot work, batch documentation and export coordination. The broader R&D platform covers more than 4,000 square meters and supports peptide research and analytical work. Facility, certificate and project claims are confirmed through current, scope-specific documentation during due diligence.

Formulation

Matrix and active compatibility review.

Array engineering

Geometry, mold and handling decisions.

Pilot transfer

Process windows and scale-risk review.

Documentation

Project specifications and traceable records.

Commercial scope

We serve skincare brands, cosmetic laboratories, professional beauty channels and cross-border distributors. Services may include cosmetic peptide raw materials, lyophilized peptide powder, dissolvable microneedle patches, oral films and OEM/ODM development. This website does not offer prescription-drug microneedle systems.

WhatsApp